Mattis Dementia Rating Scale 2
Autor: | Léonie Jean, Evelyne Matteau, Nicolas Dupré, Mélanie Langlois, Martine Simard, Pierre Provencher, Stéphanie Thivierge |
---|---|
Rok vydání: | 2011 |
Předmět: |
Male
medicine.medical_specialty Parkinson's disease Cross-sectional study Perseveration Disease Neuropsychological Tests Audiology Standard score Severity of Illness Index behavioral disciplines and activities Alzheimer Disease Memory mental disorders Severity of illness medicine Humans Dementia Psychiatry Aged Memory Disorders General Neuroscience Case-control study Middle Aged medicine.disease nervous system diseases Psychiatry and Mental health Clinical Psychology Cross-Sectional Studies Case-Control Studies Female Geriatrics and Gerontology medicine.symptom Cognition Disorders Psychology human activities |
Zdroj: | American Journal of Alzheimer's Disease & Other Dementiasr. 26:389-398 |
ISSN: | 1938-2731 1533-3175 |
Popis: | Identifying patients at higher risk of developing dementia is important. The usefulness of the Mattis Dementia Rating scale-Second Edition (MDRS-2) to detect and differentiate between patients with amnestic mild cognitive impairment (A-MCI), Parkinson’s disease and MCI (PD-MCI), PD with dementia (PDD), and Alzheimer’s disease (AD) was investigated. In all, 22 healthy controls (HC), 22 A-MCI, 22 PD-MCI, 16 PDD, and 22 AD patients were evaluated using an extensive neuropsychological battery, including the MDRS-2. The MDRS-2 total standardized score detected all groups of patients. The dementia groups performed worse than HC on the 5 MDRS-2 subscales. Alzheimer’s disease patients scored higher than PDD on MDRS-2 conceptualization and lower on memory. Healthy controls were better than PD-MCI on MDRS-2 initiation/perseveration and memory and better than A-MCI on memory. No difference was found between the MCI groups. The MDRS-2 is a suitable short scale for MCI and dementia screening but is not specific enough to differentiate between A-MCI and PD-MCI. |
Databáze: | OpenAIRE |
Externí odkaz: |